ETAEX
Price
$13.44
Change
+$0.07 (+0.52%)
Updated
Jul 28 closing price
Net Assets
95.26M
FSCSX
Price
$29.31
Change
+$0.01 (+0.03%)
Updated
Jul 28 closing price
Net Assets
10.59B
Interact to see
Advertisement

ETAEX vs FSCSX

Header iconETAEX vs FSCSX Comparison
Open Charts ETAEX vs FSCSXBanner chart's image
Eventide Exponential Technologies A
Price$13.44
Change+$0.07 (+0.52%)
VolumeN/A
Net Assets95.26M
Fidelity Select Software & IT Svcs Port
Price$29.31
Change+$0.01 (+0.03%)
VolumeN/A
Net Assets10.59B
ETAEX vs FSCSX Comparison Chart in %
Loading...
View a ticker or compare two or three
VS
ETAEX vs. FSCSX commentary
Jul 30, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ETAEX is a Hold and FSCSX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
FSCSX has more cash in the bank: 10.6B vs. ETAEX (95.3M). ETAEX (0.00) and FSCSX (0.00) have matching dividends . ETAEX was incepted earlier than FSCSX: ETAEX (5 years) vs FSCSX (40 years). ETAEX (1.74) is less costly to investors than FSCSX (0.62). ETAEX is a more actively managed with annual turnover of: 70.00 vs. FSCSX (14.00). FSCSX has a lower initial minimum investment than ETAEX: FSCSX (0) vs ETAEX (1000). ETAEX annual gain was more profitable for investors over the last year : 12.64 vs. FSCSX (9.21). FSCSX return over 5 years is better than : 24.47 vs. ETAEX (19.38).
ETAEXFSCSXETAEX / FSCSX
Total Expense Ratio1.680.62271%
Annual Report Gross Expense Ratio1.740.62281%
Fund Existence5 years40 years-
Gain YTD0.6786.81710%
Front Load6%N/A-
Min. Initial Investment10000-
Min. Initial Investment IRAN/AN/A-
Net Assets95.3M10.6B1%
Annual Yield % from dividends0.000.00-
Returns for 1 year12.649.21137%
Returns for 3 years11.4227.5641%
Returns for 5 years19.3824.4779%
Returns for 10 yearsN/A146.27-
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
FBTAX28.16N/A
N/A
Fidelity Advisor Biotechnology A
ADCVX23.08N/A
N/A
American Century Disciplined Growth A
MRLSX19.68N/A
N/A
AMG Renaissance Large Cap Growth I
REEAX15.26N/A
N/A
RBC Emerging Markets Equity A
WRCGX6.04N/A
N/A
William Blair China Growth R6